<?xml version="1.0" encoding="UTF-8"?>
<p>In October 2017, the European Commission published a ten-year report on the implementation of the Paediatric Regulation. The report showed an increase in medicines for children in most therapeutic areas over the past ten years, especially in rheumatology and infectious diseases. However, in rare diseases, progression was lower. A report on the first five years was also published in June 2013, which concluded that paediatric development had become a more integral part of the overall development of medicines in the European Union [
 <xref rid="B4-pharmaceutics-13-00387" ref-type="bibr">4</xref>,
 <xref rid="B8-pharmaceutics-13-00387" ref-type="bibr">8</xref>].
</p>
